Abstract:To elucidate the antileukemi effects of berbamine and the possible molecular mechanisms in vitro and in vivo, MTT method was used to examine the effect of berbamine on K562 cell growth. The apoptosis rate was measured by flow cytometry. The mRNA expression level of BCR/ABL gene (semiquantity value) was determined by RT-PCR and the BCR/ABL protein (P210) level was detected by Western blot. The K562-bearing mice were used to reveal the therapeutic effect in vivo. The results showed that a significant time- and concentration-dependent inhibition of cell growth was found in the cells treated with berbamine. After the cells were exposed to 8.0 microg/ml berbamine for 24, 48 and 72 hours, the percentage of growth inhibition of K562 cells progressively increased by (26.63 +/- 3.57)%, (61.84 +/- 4.74)%, (75.32 +/- 1.95)%, respectively (compared with control, P < 0.01). The IC(50) (72 hours) value was 5.227 +/- 1.307 microg/ml. The apoptosis rate of K562 cells treated with 8.0 microg/ml berbamine for 24 and 72 hours increased from (29.20 +/- 3.82)% to (61.77 +/- 4.35)% (P < 0.01). Berbamine down-regulated the expression levels of bcr/abl gene and P210 in K562 cells in a time- and concentration-dependent manner. The bcr/abl expression decreased from (1.38 +/- 0.02) to (0.97 +/- 0.01) after exposure of the cells to 8.0 microg/ml berbamine for 0 and 72 hours (P < 0.01). When the cells were treated with 4.0 - 16.0 microg/ml berbamine for 24 hours, the level of P210 decreased from (0.95 +/- 0.03) to (0.63 +/- 0.01) (P < 0.01). In vivo, after treatment for 4 weeks, the tumor weight of berbamine-treated group was also lower than that of untreated group [(1.46 +/- 0.43) g vs (2.90 +/- 0.94) g, P < 0.01] and the inhibition rate was 49.66%, moreover, berbamine down-regulated the expression level of bcr/abl gene of tumor cells. It is concluded that berbamine can obviously inhibit the cell proliferation and induce apoptosis in K562 cell lines in a time- and concentration-dependent manner in vitro. The mechanisms of berbamine-induced apoptosis may be involved in down-regulation of bcr/abl gene expression and P210 level. In vivo, berbamine can aslo display a better antileukemic effect and down-regulate expression of bcr/abl gene. Berbamine extracted from Chinese herb may be a promising candidate of new drug for clinical anticancer treatment, especially for bcr-abl(+) diseases.

Synthesis and antitumor activity in vitro of novel berbamine derivatives

Synthesis of Berbamine Acetyl Glycosides and Evaluation of Antitumor Activity.

[Effects of Berbamine on K562 Cells and Its Mechanisms in Vitro and in Vivo].

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Berbamine Exhibits Potent Antitumor Effects on Imatinib-Resistant CML Cells in Vitro and in Vivo

Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives

Studies on the Effects of Berbamine on the Human Leukemia Cell Line Nb4.

Synthetic and antitumor comparison of 9- O -alkylated and carbohydrate-modified berberine derivatives

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Design, Synthesis, and Anticancer Activity of Novel Berberine Derivatives Prepared Via CuAAC "click" Chemistry As Potential Anticancer Agents.

Synthesis and antitumor activity of novel N-substituted tetrahydro-β-carboline-imidazolium salt derivatives.

Synthesis and Biological Evaluation of 1,2,7,9-Tetrasubstituted Harmine Derivatives As Potential Antitumor Agents

Synthesis, Biological Evaluation and Mechanism Studies of C-3 Substituted Nitrogenous Heterocyclic 23-Hydroxybetulinic Acid Derivatives As Anticancer Agents

Novel Triazolyl Berberine Derivatives Prepared Via Cuaac Click Chemistry: Synthesis, Anticancer Activity and Structure-Activity Relationships

Synthesis and Anti-Tumor Activity Research of a Novel Series of 3-Amidebenzamide Derivatives

Synthesis of 8-Alkyl-13-bromo-berberine Hydrochloride Derivatives and Their Effect on Proliferation of Human HepG2 Cell Line

Synthesis and Antitumor Activity of N9 Position Aromatic Substituted Purine-8-one Derivatives

Synthesis and antitumor activity of novel 2-substituted indoline imidazolium salt derivatives

Benzoylurea Derivatives As A Novel Class of Antimitotic Agents: Synthesis, Anticancer Activity, and Structure-Activity Relationships

Synthesis and antitumor activity of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid

Synthesis and Anticancer Activity of Novel 9,13-Disubstituted Berberine Derivatives